Myriam Labopin

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Éolia Brissot, Myriam Labopin, M. Beckers et al. · Haematologica · 2014 · 160 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Immunotherapy +16

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

Charles Craddock, Myriam Labopin, Marie Robin et al. · Haematologica · 2016 · 142 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +18

Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Societe Francophone d'Histocompatibilite et d'Immunogenetique (SFHI) and Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) analysis

Annalisa Ruggeri, Vanderson Rocha, Emeline Masson et al. · Haematologica · 2012 · 133 citations · Full text

Histocompatibility, Immunohematology, Immunology +17

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia

Francesco Frassoni, Myriam Labopin, R Powles et al. · The Lancet · 2000 · 106 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +8

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD

Raphaël Carapito, Nicolas Jung, Marius Kwemou et al. · Blood · 2016 · 81 citations · Full text